Cargando…
Nuclear magnetic resonance‐based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997
AIMS: We investigated the association between quantified metabolite, lipid and lipoprotein measures and incident heart failure hospitalisation (HFH) in the elderly, and examined whether circulating metabolic measures improve HFH prediction. METHODS AND RESULTS: Overall, 80 metabolic measures from th...
Autores principales: | Delles, Christian, Rankin, Naomi J., Boachie, Charles, McConnachie, Alex, Ford, Ian, Kangas, Antti, Soininen, Pasi, Trompet, Stella, Mooijaart, Simon P., Jukema, J. Wouter, Zannad, Faiez, Ala‐Korpela, Mika, Salomaa, Veikko, Havulinna, Aki S., Welsh, Paul, Würtz, Peter, Sattar, Naveed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947152/ https://www.ncbi.nlm.nih.gov/pubmed/29226610 http://dx.doi.org/10.1002/ejhf.1076 |
Ejemplares similares
-
Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM‐HF)
por: Mogensen, Ulrik M., et al.
Publicado: (2018) -
The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma
por: Harbour, J. William, et al.
Publicado: (2013) -
Comparison of Three Troponins as Predictors of Future Cardiovascular Events – Prospective Results from the FINRISK and BiomaCaRE Studies
por: Neumann, Johannes Tobias, et al.
Publicado: (2014) -
Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort
por: Geelhoed, Bastiaan, et al.
Publicado: (2020) -
Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2021)